Cefoselis Sulfate
CAS No. 122841-12-7
Cefoselis Sulfate( Winsef )
Catalog No. M17204 CAS No. 122841-12-7
Cefoselis is a widely used beta-lactam antibiotic.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 75 | In Stock |
|
| 2MG | 32 | In Stock |
|
| 5MG | 50 | In Stock |
|
| 10MG | 76 | In Stock |
|
| 25MG | 140 | In Stock |
|
| 50MG | 219 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCefoselis Sulfate
-
NoteResearch use only, not for human use.
-
Brief DescriptionCefoselis is a widely used beta-lactam antibiotic.
-
DescriptionCefoselis sulfate is a stable cephalosporin for BETA-lactamase. The drug shows antimicrobial activity for a wide range of bacteria including Pseudomonas.(In Vitro):The activity of Cefoselis (sulfate) was similar to that of cefpirome and cefepime and generally superior to that of ceftazidime. Cefoselis sulfate showed potent antibacterial activity against Hemophilus influenzae and Moraxella catarrhalis. Cefoselis sulfate was highly active against MSSA and MSCNS. Cefoselis sulfate was poor in the activity against MRSA, MRCNS,PRSP and Enterococcus faecalis,and no activity for Enterococcus faecium.
-
In VitroThe activity of Cefoselis (sulfate) was similar to that of cefpirome and cefepime and generally superior to that of ceftazidime. Cefoselis sulfate showed potent antibacterial activity against Hemophilus influenzae and Moraxella catarrhalis.Cefoselis sulfate was highly active against MSSA and MSCNS. Cefoselis sulfate was poor in the activity against MRSA, MRCNS,PRSP and Enterococcus faecalis,and no activity for Enterococcus faecium.
-
In Vivo——
-
SynonymsWinsef
-
PathwayAutophagy
-
TargetCXCR
-
RecptorOthers
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number122841-12-7
-
Formula Weight620.64
-
Molecular FormulaC19H22N8O6S2·H2SO4
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 6.4 mg/mL. 10.31 mM
-
SMILESCO/N=C(\C1=CSC(=N1)N)/C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)CN4C=CC(=N)N4CCO)C(=O)O.OS(=O)(=O)O
-
Chemical Name(6R,7R)-7-((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-((2-(2-hydroxyethyl)-3-imino-2,3-dihydro-1H-pyrazol-1-yl)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid compound with sulfuric acid (1:1)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sugimoto M, et al. Br J Pharmacol, 2002, 135(2), 427-432.
molnova catalog
related products
-
FC131 TFA
FC131 TFA (606968-52-9 free base) (FC131 TFA) is an antagonist of CXCR4 that inhibits the binding of [125I] -sdf-1 to CXCR4(IC50 : 4.5 nM ), and has anti-hiv activity.
-
TC14012
TC14012, a serum-stable derivative of T140, is a selective and peptidomimetic CXCR4 antagonist with an IC50 of 19.3 nM. TC14012 is a potent CXCR7 agonist with an EC50 of 350 nM for recruiting β-arrestin 2 to CXCR7. TC14012 has anti-HIV activity and anti-cancer activity.
-
SX-682
SX-682 is a potent, selective and orally bioavailable inhibitor of CXCR1/2 ,has the potential to treat castration-resistant prostate cancer.
Cart
sales@molnova.com